Akoya Historical Cash Flow

AKYA Stock  USD 2.20  0.06  2.80%   
Analysis of Akoya Biosciences cash flow over time is an excellent tool to project Akoya Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 11.8 M or Net Borrowings of 37.4 M as it is a great indicator of Akoya Biosciences ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Akoya Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Akoya Biosciences is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akoya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.

About Akoya Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Akoya balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Akoya's non-liquid assets can be easily converted into cash.

Akoya Biosciences Cash Flow Chart

At present, Akoya Biosciences' Investments are projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 11.8 M, whereas Change To Inventory is forecasted to decline to (6.6 M).

Investments

Securities or assets acquired for generating income or appreciating in value, not used in daily operations.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Capital Expenditures

Capital Expenditures are funds used by Akoya Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Akoya Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Akoya Biosciences financial statement analysis. It represents the amount of money remaining after all of Akoya Biosciences operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.
Most accounts from Akoya Biosciences' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Akoya Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akoya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.At present, Akoya Biosciences' Investments are projected to increase significantly based on the last few years of reporting. The current year's Change In Cash is expected to grow to about 11.8 M, whereas Change To Inventory is forecasted to decline to (6.6 M).

Akoya Biosciences cash flow statement Correlations

-0.4-0.03-0.65-0.760.790.75-0.59-0.64-0.47-0.450.84-0.570.260.72-0.58-0.43-0.660.75-0.720.72-0.73
-0.40.110.810.82-0.63-0.80.480.750.980.3-0.170.250.42-0.690.540.7-0.04-0.830.73-0.720.75
-0.030.11-0.30.06-0.07-0.29-0.32-0.010.280.01-0.12-0.740.61-0.040.510.220.610.16-0.250.25-0.23
-0.650.81-0.30.93-0.85-0.640.860.890.780.61-0.260.60.1-0.890.550.740.04-0.980.98-0.980.99
-0.760.820.060.93-0.96-0.770.820.940.870.69-0.370.370.29-0.970.810.860.36-0.970.95-0.950.96
0.79-0.63-0.07-0.85-0.960.62-0.89-0.92-0.72-0.840.35-0.3-0.270.99-0.87-0.87-0.510.89-0.920.93-0.92
0.75-0.8-0.29-0.64-0.770.62-0.32-0.64-0.82-0.120.71-0.37-0.070.6-0.54-0.48-0.40.76-0.620.61-0.65
-0.590.48-0.320.860.82-0.89-0.320.890.510.84-0.10.430.12-0.90.660.810.22-0.820.92-0.930.91
-0.640.75-0.010.890.94-0.92-0.640.890.80.69-0.230.310.3-0.940.810.930.31-0.910.92-0.920.92
-0.470.980.280.780.87-0.72-0.820.510.80.41-0.210.130.53-0.770.70.790.15-0.830.74-0.730.76
-0.450.30.010.610.69-0.84-0.120.840.690.410.080.010.41-0.850.770.780.4-0.590.71-0.720.7
0.84-0.17-0.12-0.26-0.370.350.71-0.1-0.23-0.210.08-0.540.520.26-0.20.02-0.60.4-0.30.3-0.32
-0.570.25-0.740.60.37-0.3-0.370.430.310.130.01-0.54-0.72-0.28-0.18-0.04-0.17-0.570.56-0.560.56
0.260.420.610.10.29-0.27-0.070.120.30.530.410.52-0.72-0.330.590.610.08-0.110.1-0.10.1
0.72-0.69-0.04-0.89-0.970.990.6-0.9-0.94-0.77-0.850.26-0.28-0.33-0.86-0.9-0.420.91-0.940.94-0.94
-0.580.540.510.550.81-0.87-0.540.660.810.70.77-0.2-0.180.59-0.860.910.68-0.640.65-0.650.65
-0.430.70.220.740.86-0.87-0.480.810.930.790.780.02-0.040.61-0.90.910.34-0.760.79-0.790.78
-0.66-0.040.610.040.36-0.51-0.40.220.310.150.4-0.6-0.170.08-0.420.680.34-0.190.19-0.190.19
0.75-0.830.16-0.98-0.970.890.76-0.82-0.91-0.83-0.590.4-0.57-0.110.91-0.64-0.76-0.19-0.980.97-0.98
-0.720.73-0.250.980.95-0.92-0.620.920.920.740.71-0.30.560.1-0.940.650.790.19-0.98-1.01.0
0.72-0.720.25-0.98-0.950.930.61-0.93-0.92-0.73-0.720.3-0.56-0.10.94-0.65-0.79-0.190.97-1.0-1.0
-0.730.75-0.230.990.96-0.92-0.650.910.920.760.7-0.320.560.1-0.940.650.780.19-0.981.0-1.0
Click cells to compare fundamentals

Akoya Biosciences Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Akoya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akoya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akoya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akoya Biosciences Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akoya Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For information on how to trade Akoya Stock refer to our How to Trade Akoya Stock guide.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akoya Biosciences. If investors know Akoya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akoya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.16)
Revenue Per Share
1.889
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.18)
Return On Equity
(1.28)
The market value of Akoya Biosciences is measured differently than its book value, which is the value of Akoya that is recorded on the company's balance sheet. Investors also form their own opinion of Akoya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Akoya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akoya Biosciences' market value can be influenced by many factors that don't directly affect Akoya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akoya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akoya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akoya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.